ADAPT - A Patient Registry of the Real-world Use of Orenitram®
Phase of Trial: Phase IV
Latest Information Update: 20 Dec 2017
At a glance
- Drugs Treprostinil (Primary)
- Indications Pulmonary arterial hypertension
- Focus Adverse reactions
- Acronyms ADAPT
- Sponsors United Therapeutics Corporation
- 13 Dec 2017 Planned End Date changed from 1 Jun 2019 to 1 Jan 2019.
- 13 Dec 2017 Planned primary completion date changed from 1 Jun 2019 to 1 Jan 2019.
- 18 Jul 2017 Status changed from not yet recruiting to recruiting.